XJPX4934
Market cap45mUSD
Jan 21, Last price
811.00JPY
1D
0.37%
1Q
12.80%
IPO
-87.04%
Name
Premier Antiaging Co Ltd
Chart & Performance
P/E
—
P/S
0.35
EPS
—
Div Yield, %
—
Shrs. gr., 5y
0.05%
Rev. gr., 5y
11.29%
Revenues
20.36b
-22.88%
Net income
-1.48b
L+102.05%
CFO
425m
-82.46%
Profile
Premier Anti-Aging Co., Ltd. engages in the planning, development, import/export, mail order, wholesale, and retail business of cosmetics and health foods. The company offers its cosmetic products under the DUO and CANADEL brands. It is also involved on the information provision and consulting services related to anti-aging, beauty, and health; research on management and beauty of beauty clinics, etc.; and marketing research and collection and analysis of various information. The company was founded in 2009 and is headquartered in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2024‑07 | 2023‑07 | 2022‑07 | 2021‑07 | 2020‑07 | 2019‑07 | 2018‑07 | |
| Income | |||||||
Revenues | 20,359,000 -22.88% | 26,400,665 -22.15% | 33,911,903 3.35% | ||||
Cost of revenue | 4,258,000 | 27,032,347 | 31,497,584 | ||||
Unusual Expense (Income) | |||||||
NOPBT | 16,101,000 | (631,682) | 2,414,319 | ||||
NOPBT Margin | 79.09% | 7.12% | |||||
Operating Taxes | 581,000 | 74,488 | 1,147,904 | ||||
Tax Rate | 3.61% | 47.55% | |||||
NOPAT | 15,520,000 | (706,170) | 1,266,415 | ||||
Net income | (1,483,000) 102.05% | (733,974) -151.53% | 1,424,422 -49.01% | ||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | (192) | ||||||
BB yield | 0.00% | ||||||
| Debt | |||||||
Debt current | 1,419,000 | 824,844 | 712,114 | ||||
Long-term debt | 1,023,000 | 1,436,727 | 701,114 | ||||
Deferred revenue | 38,438 | ||||||
Other long-term liabilities | 98,000 | 3 | 30,774 | ||||
Net debt | (2,328,000) | (2,440,485) | (1,600,431) | ||||
| Cash flow | |||||||
Cash from operating activities | 425,000 | 2,422,540 | (3,322,340) | ||||
CAPEX | (629,000) | (778,322) | (203,339) | ||||
Cash from investing activities | (540,000) | (900,970) | (297,682) | ||||
Cash from financing activities | 183,000 | 179,774 | 501,623 | ||||
FCF | 14,583,973 | 3,769,290 | (3,721,412) | ||||
| Balance | |||||||
Cash | 4,760,000 | 4,670,475 | 2,973,269 | ||||
Long term investments | 10,000 | 31,581 | 40,390 | ||||
Excess cash | 3,752,050 | 3,382,023 | 1,318,064 | ||||
Stockholders' equity | 4,772,000 | 6,259,180 | 6,997,787 | ||||
Invested Capital | 4,909,950 | 5,115,761 | 8,308,233 | ||||
ROIC | 309.60% | 26.86% | |||||
ROCE | 185.88% | 25.08% | |||||
| EV | |||||||
Common stock shares outstanding | 8,720 | 8,720 | 8,733 | ||||
Price | 866.00 -19.07% | 1,070.00 -46.37% | 1,995.00 -86.88% | ||||
Market cap | 7,551,848 -19.07% | 9,330,806 -46.44% | 17,422,279 -86.86% | ||||
EV | 5,223,848 | 6,890,321 | 15,821,848 | ||||
EBITDA | 16,351,000 | (423,235) | 2,499,772 | ||||
EV/EBITDA | 0.32 | 6.33 | |||||
Interest | 22,000 | 18,794 | 14,879 | ||||
Interest/NOPBT | 0.14% | 0.62% | |||||